+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Paediatric Consumer Health in Canada

  • PDF Icon

    Report

  • 27 Pages
  • September 2024
  • Region: Canada
  • Euromonitor International
  • ID: 4752921
Paediatric consumer health is set to see modest current value growth in Canada in 2024. Paediatric cough/cold remedies and paediatric analgesics are expected to see declining sales during the year as these categories continue to normalise after the massive spike in demand in 2022, which was caused by the flu/RSV/COVID “triple-demic” and led to shortages of such products. In 2024, most regions of Canada saw a return to more “normal” flu seasons compared to 2022, which served to lower demand.

The Paediatric Consumer Health in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Paediatric Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Normalisation dampens demand for paediatric analgesics and cough/cold remedies
  • Zarbee’s launches in Canada
  • Paediatric vitamins and dietary supplements bounces back
PROSPECTS AND OPPORTUNITIES
  • Demand to be supported by ongoing interest in health and immunity
  • Climate change to contribute to rise in demand for paediatric allergy remedies
  • Immigration to boost population aged between 0 and 4 years
CATEGORY DATA
  • Table 1 Sales of Paediatric Consumer Health by Category: Value 2019-2024
  • Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
  • Table 4 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
  • Table 5 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
  • Table 6 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN CANADA
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources